華脈科技(603042.SH):上海金融擬減持不超2%的股份
格隆匯1月9日丨華脈科技(603042.SH)公佈,截至公告披露日,上海金融發展投資基金(有限合夥)(“上海金融”)持有公司股份1118.14萬股,佔公司總股本8.22%。上述股份來源於首次公開發行前持有的股份。
出於經營計劃需要,上海金融自公告披露之日起15個交易日後6個月內,擬通過集中競價方式減持公司股份不超過272萬股,即不超過公司股份總數的2%,且在任意連續90日內,減持股份的總數不超過公司股份總數的1%;減持價格按照實施時市場價格確定,且不低於公司股票的發行價。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.